Provided by Tiger Trade Technology Pte. Ltd.

BioAtla, Inc.

0.1532
-0.0168-9.88%
Post-market: 0.1514-0.0018-1.17%18:12 EDT
Volume:821.37K
Turnover:129.38K
Market Cap:12.69M
PE:-0.13
High:0.1690
Open:0.1560
Low:0.1506
Close:0.1700
52wk High:1.43
52wk Low:0.1300
Shares:82.85M
Float Shares:69.15M
Volume Ratio:0.70
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1495
EPS(LYR):-1.4365
ROE:-813.88%
ROA:-105.08%
PB:-0.41
PE(LYR):-0.11

Loading ...

BioAtla Shareholders Approve Merger and Share Consolidation

TIPRANKS
·
Mar 24

Bioatla Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
Mar 23

BRIEF-Bioatla Inc - Announces 70% Workforce Reduction - SEC Filing

Reuters
·
Mar 02

Bioatla Inc - Chris Vasquez Appointed as CFO Effective March 2, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 02

BioAtla initiates evaluation of strategic options, reduces workforce by 70%

TIPRANKS
·
Mar 02

BRIEF-Bioatla Announces Formal Process To Evaluate Strategic Options To Monetize Assets

Reuters
·
Mar 02

BioAtla launches restructuring plan with 70% workforce cut

Reuters
·
Mar 02

Bioatla Inc - Exploring Options Include Sale of Assets, Licensing, Partnerships

THOMSON REUTERS
·
Mar 02

Bioatla Inc - to Reduce Workforce by About 70%

THOMSON REUTERS
·
Mar 02

Press Release: BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets

Dow Jones
·
Mar 02

BioAtla Faces Nasdaq Trading Suspension and Potential Delisting

TIPRANKS
·
Feb 07

BioAtla Faces Nasdaq Delisting Over Listing Rule Violations

Reuters
·
Feb 07

BioAtla Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jan 31

BioAtla Pursues Share Consolidation Amid Nasdaq Compliance Dispute

TIPRANKS
·
Jan 31

BioAtla files $200M mixed securities shelf

TIPRANKS
·
Jan 17

Bioatla Inc : Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

THOMSON REUTERS
·
Jan 17

BioAtla initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
Jan 14

BioAtla Creates Super-Voting Share to Advance Reverse Split

TIPRANKS
·
Jan 13

BioAtla Inc. Held Special Shareholder Meeting

Reuters
·
Jan 13

BioAtla Partners with Inversagen AI to Advance Oz-V Senolytic Therapy for OPSCC

Reuters
·
Dec 31, 2025